- Genset SA
- Abbott Laboratories Inc.
- Schering-Plough Corp.
- Duke University
- Glaxo Wellcome PLC
- Affymetrix Inc.
- Incyte Corp.
- Oscient Pharmaceuticals Corp.
- Takeda Oncology
- Genaissance Pharmaceuticals Inc.
- Nova Molecular Inc.
- Human Genome Sciences Inc.
- Myriad Genetics Inc.
- Millennium BioTherapeutics Inc.
- Hexagen PLC
- Synthelabo SA
- Eli Lilly & Co.
- Novo Nordisk AS
- Dana-Farber Cancer Institute
- Memorial Sloan Kettering Cancer Center
- Genos Biosciences Inc.
- Pharmaceutical Product Development Inc.
- UnitedHealth Group Co.
- Applied Biosystems Inc.
- Visible Genetics Inc.
- Hyseq Pharmaceuticals Inc.
- Avitech Diagnostics Inc.
- Chugai Pharmaceutical Co. Ltd.
- Gen-Probe Inc.
- Becton Dickinson & Co.
- Bayer AG
- Genset and Abbott enter pharmacogenomics alliance
- Glaxo buys genomics firm Spectra Biomedical for $9mm
- Progenitor acquires Mercator Genetics in $30mm stock swap
- Genome Therapeutics, Schering-Plough collaborate vs. asthma
- J&J invests in Genset; Janssen may collaborate
- SmithKline, Incyte form 50/50 diagnostics JV, diaDeXus LLC
- Sequana and Sloan-Kettering form cancer genetics JV Genos
- PPD buys genomic discovery tool from Ingenex
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.